Skip to main content

Market Overview

UPDATE: BMO Capital Markets Reiterates on Endologix Following Stronger 3Q13 Estimates


In a report published Thursday, BMO Capital Markets analyst Joanne K. Wuensch reiterated an Outperform rating on Endologix (NASDAQ: ELGX), and raised the price target from $18.00 to $20.00.

In the report, BMO Capital Markets noted, “ELGX reported 3Q13 estimates that were better than expected, providing an update on the product pipeline. 3Q13 revenue of $33.3 million (up 25%) was ahead of the consensus's $32.5 million estimate. In the US, revenue was $26.5 million (up 24% y/y) seemingly moving through the normal summer slowdown, driven by the continued adoption of its AFX system and enhanced sales force productivity. OUS sales were $6.8 million (up 26%), where the normal summer seasonal patterns were evident, despite strong procedural growth, and a continued direct sales transition in Europe. EPS were a loss of $0.02, better than the consensus's loss of $0.05. On guidance: the revenue range was narrowed to $131-$133 million (up 24%-25%) from $128-$134 million (versus consensus's $132.8 million), and non-GAAP EPS to a loss of $0.14-$0.18 from a loss of $0.18-$0.22 (and consensus's loss of $0.18).”

Endologix closed on Wednesday at $17.07.

Latest Ratings for ELGX

May 2020BTIGDowngradesBuyNeutral
Mar 2020Stephens & Co.MaintainsEqual-Weight
Feb 2020Stephens & Co.MaintainsEqual-Weight

View More Analyst Ratings for ELGX
View the Latest Analyst Ratings


Related Articles (ELGX)

View Comments and Join the Discussion!

Posted-In: BMO Capital Markets Joanne K. WuenschAnalyst Color Price Target Analyst Ratings

Latest Ratings

PBTruist SecuritiesMaintains88.0
CFRTruist SecuritiesMaintains111.0
FANGTruist SecuritiesMaintains105.0
SBNYCredit SuisseMaintains250.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at